Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01347879 · ClinicalTrials.gov registry record · Phase 2
A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris
A Phase 2 study, sponsored by Photocure.
- Completed
- Registry status
- Phase 2
- Development phase
- 153
- Enrollment target
NCT01347879 is a Phase 2 study that has completed, run by Photocure. The registered enrollment target is 153 participants.
The verdict
NCT01347879, a Phase 2 study, has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 153 participants
- Enrollment target
Study Summary
This study is intended to evaluate the efficacy and safety of Visonac Photodynamic Therapy (PDT) in patients with severe acne, score 4 on global IGA scale. The null hypothesis is that Visonac PDT is equal to vehicle PDT against the alternative hypothesis that Visonac PDT is different compared to vehicle PDT at week 12.
Interventions
- DRUG Visonac PDT
- DRUG Vehicle cream with PDT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01347879
The ClinicalTrials.gov registry entry for NCT01347879 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Photocure, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Visonac PDT is the first listed.
NCT01347879 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01347879 about?
NCT01347879 is a clinical study titled "A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris". This study is intended to evaluate the efficacy and safety of Visonac Photodynamic Therapy (PDT) in patients with severe acne, score 4 on global IGA scale. The null hypothesis is that Visonac PDT is equal to vehicle PDT against the alternative hypothesis that Visonac PDT is different compared to veh...
What is the current status of trial NCT01347879?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 153 participants. The study started on 2011-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01347879?
The interventions under investigation include: Visonac PDT (DRUG), Vehicle cream with PDT (DRUG).
Who is sponsoring clinical trial NCT01347879?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.